Orchestra BioMed Holdings Inc. (OBIO)
OBIO trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$5.72
-3.21% on the day
Market cap
$343.8M
Small cap
Revenue · 2025
$33.5M
+1169.2% on 2024
Net income · 2025
-$52.7M
-157.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | OBIO on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001814114 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $33.5M |
| Net income | -$52.7M |
| Operating income | -$51.8M |
| Net margin | -157.4% |
| Operating margin | -154.7% |
| Revenue growth | +1169.2% |
| Cash | $34.7M |
| Total assets | $114.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 10.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-11-21 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report FORM 8-K | 8-K | 2026-10-01 |
| Latest proxy | DEFA14A | 2026-06-16 |
Source: SEC EDGAR submissions feed, 409 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.6% |
| 1 month | -6.9% |
| 3 months | +51.2% |
| Year to date | +35.5% |
| 1 year | +76.3% |
| From 52-week high | -11.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
| USNA | USANA Health Sciences Inc. | $15.46 | +3.41% | $285.6M |
| SNDL | SNDL Inc. Common Shares | $1.16 | -0.85% | $285.5M |
| ACB | Aurora Cannabis Inc. Common Shares | $4.29 | -1.38% | $265.8M |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
| NAGE | Niagen Bioscience Inc. | $2.58 | -1.90% | $204.1M |
| MDWD | MediWound Ltd. | $12.22 | -2.71% | $157.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier